Publisher
Springer International Publishing
Reference19 articles.
1. Chiba, M., Sanada, Y., Kawano, S., Murofushi, M., Okada, I., Yoshizawa, Y., Gomi, A., Yatsuzuka, M., Toki, A., & Hirai, Y. (2007). Glicentin inhibits internalization of enteric bacteria by cultured INT-407 enterocytes. Pediatric Surgery International, 23, 551–554.
2. Fiocca, R., Capella, C., Buffa, R., Fontana, R., Solcia, E., Hage, E., Chance, R. E., & Moody, A. J. (1980). Glucagon-, glicentin-, and pancreatic polypeptide-like immunoreactivities in rectal carcinoids and related colorectal cells. The American Journal of Pathology, 100, 81–92.
3. Fiocca, R., Rindi, G., Capella, C., Grimelius, L., Polak, J. M., Schwartz, T. W., Yanaihara, N., & Solcia, E. (1987). Glucagon, glicentin, proglucagon, PYY, PP and proPP-icosapeptide immunoreactivities of rectal carcinoid tumors and related non-tumor cells. Regulatory Peptides, 17, 9–29.
4. Gribble, F. M., Reimann, F., & Roberts, G. (2018). Gastrointestinal hormones. In H. M. Said (Ed.), Physiology of the gastrointestinal tract (6th ed., pp. 31–70). Elsevier.
5. Hamid, Q. A., Bishop, A. E., Sikri, K. L., Varndell, I. M., Bloom, S. R., & Polak, J. M. (1986). Immunocytochemical characterization of 10 pancreatic tumours, associated with the glucagonoma syndrome, using antibodies to separate regions of the pro-glucagon molecule and other neuroendocrine markers. Histopathology, 10, 119–133.